AVOLLA - Trademark Details
Status: 606 - Abandoned - No Statement Of Use Filed
Serial Number
87641245
Word Mark
AVOLLA
Status
606 - Abandoned - No Statement Of Use Filed
Status Date
2021-06-21
Filing Date
2017-10-11
Mark Drawing
4000 - Standard character mark
Typeset
Published for Opposition Date
2018-03-20
Law Office Assigned Location Code
L40
Employee Name
MARTIN, CHRISTINE C
Statements
Goods and Services
Pharmaceutical preparations for the prevention and treatment of Alzheimer's disease; Pharmaceutical preparations for the prevention and treatment of depression; Pharmaceutical preparations for the prevention and treatment of psychological disorders; Pharmaceutical preparations for the prevention and treatment of diabetes and diabetic neuropathy; Pharmaceutical preparations for the prevention and treatment of cardiovascular and blood pressure disorders; Pharmaceutical preparations for the prevention and treatment of irritable bowel syndrome; Pharmaceutical preparations for the prevention and treatment of neurodegenerative diseases and disorders; Pharmaceutical preparations for the prevention and treatment of osteoporosis; Pharmaceutical preparations for the prevention and treatment of pain and neuropathic pain; Pharmaceutical preparations for the prevention and treatment of peripheral nervous system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of digestive tract, gastrointestinal and dermatological diseases and disorders; Pharmaceutical preparations for the prevention and treatment of respiratory system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of sexual dysfunction; Pharmaceutical preparations for the prevention and treatment of symptoms associated with uterine fibroids; Pharmaceutical preparations for the prevention and treatment of urinary incontinence and overactive bladder; Pharmaceutical preparations for the prevention and treatment of AIDS-related disorders; Pharmaceutical preparations that support, encourage and promote bone strength; Pharmaceutical preparations that support, encourage and promote bone health; Pharmaceutical preparations used in the treatment of bone disorders and bone diseases; Pharmaceutical preparations, namely injectable contraceptives; Pharmaceutical preparations, namely, contraceptive preparations; Pharmaceutical preparations, namely fertility enhancement preparations; Pharmaceutical preparations, namely, hormone replacement therapy preparations; Pharmaceutical preparations for the treatment of cancer; Pharmaceutical agents affecting the central nervous system; Pharmaceutical agents affecting circulatory systems; Pharmaceutical agents affecting sensory organs; Pharmaceutical agents affecting urogenital organs; Pharmaceutical agents affecting peripheral nervous system
Classification Information
International Class
005 - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes
006, 018, 044, 046, 051, 052
Class Status Code
6 - Active
Class Status Date
2017-10-18
Primary Code
005
Correspondences
Name
Teva Pharmaceuticals USA, Inc.
Address
Please log in with your Justia account to see this address.
Trademark Events
Event Date | Event Description |
2017-10-14 | NEW APPLICATION ENTERED IN TRAM |
2017-10-18 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
2018-01-10 | ASSIGNED TO EXAMINER |
2018-01-11 | NON-FINAL ACTION WRITTEN |
2018-01-11 | NON-FINAL ACTION E-MAILED |
2018-01-11 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
2018-01-17 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
2018-01-17 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
2018-01-17 | TEAS/EMAIL CORRESPONDENCE ENTERED |
2018-01-19 | APPROVED FOR PUB - PRINCIPAL REGISTER |
2018-02-02 | ASSIGNED TO LIE |
2018-02-28 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
2018-03-20 | PUBLISHED FOR OPPOSITION |
2018-03-20 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
2018-05-15 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
2018-11-12 | TEAS EXTENSION RECEIVED |
2018-11-12 | EXTENSION 1 FILED |
2018-11-12 | EXTENSION 1 GRANTED |
2018-11-14 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
2019-05-08 | TEAS EXTENSION RECEIVED |
2019-05-08 | EXTENSION 2 FILED |
2019-05-08 | EXTENSION 2 GRANTED |
2019-05-10 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
2019-11-13 | TEAS EXTENSION RECEIVED |
2019-11-13 | EXTENSION 3 FILED |
2019-11-13 | EXTENSION 3 GRANTED |
2019-11-15 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
2019-11-13 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
2020-05-05 | TEAS EXTENSION RECEIVED |
2020-05-05 | EXTENSION 4 FILED |
2020-05-05 | EXTENSION 4 GRANTED |
2020-05-07 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
2020-11-09 | TEAS EXTENSION RECEIVED |
2020-11-23 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
2020-11-09 | EXTENSION 5 FILED |
2020-11-24 | EXTENSION 5 GRANTED |
2020-11-25 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
2021-06-21 | ABANDONMENT - NO USE STATEMENT FILED |
2021-06-21 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |